you can see. Ozempic Bone
you can't.
The same caloric stress that gave you the body back is quietly emptying your bone marrow. Thryve is the first formula that fixes the signal — not the mineral.
FDA Wegovy label
AAOS '26 · n=73,000
before menopause
The other you notice in the ER.
Jawline back. Jeans from 2019 fit again. Doctor congratulates her at the annual. Forty pounds in eight months. It worked.
Trabecular bone — the honeycomb inside her hips and spine — is thinning at twice the rate of menopause alone. She won't know until the fall. Or the scan.
"You did the hard thing. The weight loss is real. But the same caloric stress that drove the win is depleting the one signal your bone marrow needs. You earned the outside result. You didn't know it was costing you the inside structure."
the wrong problem.
Bone loss after rapid weight loss isn't a mineral problem. It's a signal problem. Your body has the calcium. It doesn't have the workers to use it.
The signal that tells marrow stem cells "become bone builders" is NAD+ — and it's been falling since your 40s. Menopause cut it again. GLP-1 caloric restriction is cutting it a third time.
Calcium = groceries on the counter. Plenty of them. Nobody to cook with them.
NAD+ = the signal that brings the chefs in. Now the groceries become meals.
"I need more calcium."
The signal that turns marrow stem cells into bone builders.
Restores the signal. The minerals you already have can finally be used.
The signal told it what to make.
Inside every long bone is a stem-cell pool that can become two things: a bone builder or a fat cell. NAD+ is the foreman. When it's loud, builders. When it goes quiet — fat.
Marrow is dense, pink, signaling. Stem cells default to becoming osteoblasts — the workers that lay down new bone every day.
Marrow fills with fat. Stem cells take the path of least resistance — they become adipocytes. The factory makes the wrong product.
Caloric restriction + age + menopause drop NAD+ below the threshold marrow needs to keep choosing "builder."
The same cell that could have been a bone builder defaults to becoming a fat cell. Daily, quietly, for years.
Resorption keeps running on schedule. Now there's nobody to rebuild behind it.
DEXA score slides from osteopenia to osteoporosis. The fall doesn't cause the fracture. The marrow did.
Clear the way.
We could have put twenty things on the back of the bottle. We put three — because three is what the mechanism actually needs, and anything else would have diluted the dose.
Refills the foreman so marrow stem cells hear the order to become bone builders.
NAD+ is the molecule that tells marrow which cell type to become. By 60, you have roughly half of what you had at 40. GLP-1 caloric restriction drops it further. We dose 500 mg of a stabilized precursor — the level used in the human studies that moved stem cells back toward the builder lineage.
Makes the NAD+ signal louder and gives a gentle estrogen-mimic boost where bone needs it.
Activates the sirtuin pathway that NAD+ depends on, and binds bone's estrogen receptors enough to keep building cues alive after menopause. In a year-long human trial, this dose added +0.016 g/cm² at the lumbar spine — a meaningful number when the rest of the curve is going the other way.
Sweeps out worn-out "zombie" cells in marrow that leak inflammation and push neighbors toward fat.
Senescent cells accumulate with age and weight loss. They don't die. They sit there leaking signals that nudge nearby stem cells away from becoming bone. Quercetin selectively clears them — the same compound used in the senolytic protocols at Mayo and the Buck Institute.
They're not small.
higher hip-fracture rate on FDA Wegovy label.
1.0% vs 0.2% in trial population.
higher osteoporosis risk for GLP-1 users.
AAOS 2026 · 73,000-patient retrospective.
risk for non-diabetic women using GLP-1 for weight loss.
subgroup analysis of same cohort.
NAD+ decline between ages 40 and 60.
Menopause and caloric restriction both accelerate further.
you can't see in the mirror.
Bone is slow. It rebuilds on a 90- to 120-day cycle. The good news: once the signal is back, the work compounds. The first six months stabilize you. The next six start moving the number.
Cellular energy rises first. You may notice afternoon clarity before you notice anything skeletal.
Marrow signaling shifts. Quercetin clears the senescent cells that were leaking inflammation onto fresh stem cells.
P1NP and osteocalcin trend up on bloodwork. You won't feel it. The lab will see it.
The slide stops. Resveratrol's estrogen-mimic action keeps the brakes on resorption at the lumbar spine.
A meaningful T-score move shows up on imaging — the conversation with your doctor becomes different.
Keep what you earned.
- · Free U.S. shipping
- · Founder-included pause anytime
- · Free U.S. shipping
- · Founder-included pause anytime
- · Save $69 vs single bottle
- · Free U.S. shipping
- · Founder-included pause anytime
- · Save $138 vs single bottle
- · Reaches month 5 — start of the second density cycle
Ships within 1 business day from Boulder, CO. Free U.S. shipping. Comes with the founder's enclosed note and your starting baseline worksheet.
paying attention.
Most women on a GLP-1 will find out about their bones the hard way — from a scan, or a slip on the ice, or a wrist that won't quite stop hurting. You found out early. You read this far. You're the woman who kept both the weight loss and the skeleton.
That's not a marketing line. It's just what the next ten years look like for the women who started in time.
It's not in the commercial. It's not on the warning sticker. But it is printed in 7-point type on page 38 of the FDA's own Wegovy label — and a 73,000-patient study published this year just confirmed what the label has quietly admitted all along.
What you're about to read may be the single most important eleven minutes you spend on your body this year. Please read every word.
Dear friend,
If you've been using a GLP-1 medication for weight loss — or you're thinking about starting one — I need you to put down whatever else you're doing for the next eleven minutes.
Because there is something happening inside your body right now that almost no one is telling you about. Not your doctor. Not the drug commercial. Not the women in the Facebook groups celebrating their forty-pound before-and-afters.
It is quiet. It is invisible. It doesn't hurt. You won't feel it.
Until one morning you slip on a wet kitchen tile, put your hand out to catch yourself, and shatter your wrist in three places. At fifty-eight. With no warning. From a fall a thirty-year-old would walk away from.
And in the ER, the orthopedist will look at your scan and say something that will stay with you for the rest of your life:
"Your bones look like a woman fifteen years older than you."
Pull up the official FDA label for Wegovy. Scroll to page 38. Section 6.1, "Clinical Trials Experience."
Buried in a table of "less common adverse reactions" — the section nobody reads — is a single line item:
Hip fracture: 1.0% on Wegovy vs 0.2% on placebo.
That is a five-times higher rate of broken hips. In a trial that ran a little over a year.
Five times. Printed in the label. Quietly approved. Never mentioned in the thirty-second commercials where a woman in her fifties dances around her kitchen.
If you fracture a hip after sixty, your one-year mortality risk is roughly 1 in 4. That isn't a side effect. That's a different life.
You may be thinking: "That's the trial population. Older diabetics. Sicker patients. Not me."
That's exactly what I thought. Until February.
In February of 2026, the American Academy of Orthopaedic Surgeons published the largest analysis ever done on GLP-1 use and bone health. 73,000 patients. Real-world data. Not a marketing-funded trial.
The headline finding:
- +29% higher risk of osteoporosis across all GLP-1 users.
- +22% higher risk in the specific subgroup that matters most to me — and probably to you — non-diabetic women using a GLP-1 purely for weight loss.
- And the effect did not go away after the weight stabilized. The bone loss kept compounding even after the scale stopped moving.
If you are a woman over fifty using a GLP-1 right now, the math is brutal:
Your bones are being eroded by three forces at the same time — and almost no one is connecting the dots between them:
1. Age. Your bone-building signal (NAD+) is already half of what it was at forty.
2. Menopause. The estrogen that protected your skeleton for forty years is gone.
3. GLP-1 caloric restriction. The same caloric stress that drove the weight loss is now cutting that bone-building signal a third time.
One of these is a problem. Two is serious. Three at once is what gives you a femur fracture from stepping off a curb at sixty-two.
I know. So was every woman I just described.
Here's the part nobody told you: this is not a calcium problem. If it were, half a century of "drink your milk" advice would have prevented every hip fracture in America. It hasn't.
Bone loss after rapid weight loss is not a mineral problem.
It is a signal problem.
Inside every long bone in your body — your hips, your spine, your femur — there is a soft pink tissue called bone marrow. And inside that marrow lives a population of stem cells with two possible futures:
- They can become bone builders — the cells that lay down fresh new bone every single day.
- Or they can become fat cells — useless little blobs of stored grease.
Which one do they become? That depends entirely on a single molecule. Its name is NAD+. Think of it as the foreman of the marrow factory.
When NAD+ is loud and plentiful — like it was when you were thirty — the foreman walks the floor and points at every stem cell: "You. Builder. You. Builder. You. Builder."
When NAD+ goes quiet — and it does, by 50% before you even hit sixty — there is no foreman. The stem cells take the path of least resistance. They become fat.
13% fat
69% fat
Now do you see why calcium can't save you?
You can deliver all the calcium in the world to your marrow. If there are no builders left to use it, it just sits there.
It's like delivering groceries to a kitchen that has no chefs. You can pile the bags up to the ceiling. Nobody is going to cook.
What you thought: "I'm losing bone density because I'm not getting enough calcium."
What's actually happening: Your marrow has stopped making the cells that use calcium. The signal that tells stem cells "become a builder" has gone quiet. The minerals you already have can't be put to work.
Bone has no nerves. You cannot feel it thinning, the way you can feel a muscle weakening. You can run a 5K with a hip the density of a Triscuit and never know.
DEXA scans — the only test that catches this — are recommended every two years, and most insurance only pays for one starting at sixty-five. By the time the scan catches it, the damage has been compounding silently for a decade.
The first time most women find out is the moment something breaks.
And here is the cruelest part: after the first fracture, you are nearly three times more likely to have a second one within a year. The skeleton enters a kind of cascade. Wrist becomes hip becomes spine becomes a walker becomes assisted living.
That is not the next chapter you signed up for when you started a GLP-1 to take the weight off.
Here is the good news, and I want you to hear me on this: bone is alive. Every single day your body is breaking down old bone and laying down new bone. The whole skeleton turns over roughly every ten years.
Which means the damage being done right now — quietly, daily — is also reversible. If you restore the signal.
The science is settled on this. When NAD+ levels rise, marrow stem cells move back toward the builder lineage. When they move back to builder, density stabilizes. Then it climbs.
The catch is biological speed. Bone rebuilds on a 90- to 120-day cycle. Every month you wait is a month the marrow shifts further toward fat — and a month longer it will take to shift back.
This is not stock-clock urgency. This is the urgency of a tissue that responds slowly to good news.
So here is the question I want to put in front of you. Take a breath before you answer it.
Most of the women I've spoken to over the last year said yes before I finished the sentence.
So let me tell you what we built.
The NAD+ Bone Formula.
The first supplement on the market built — not for the general "bone health" shelf — but for the woman whose bones are being eroded by a GLP-1.
Refills the foreman.
NAD+ is the molecule that tells marrow which cell type to become. By sixty, you have roughly half of what you had at forty. GLP-1 caloric restriction drops it further. We dose 500 mg of a stabilized precursor — the level used in the human studies that moved stem cells back toward the builder lineage.
Makes the signal louder.
Activates the sirtuin pathway that NAD+ depends on, and binds bone's estrogen receptors enough to keep building cues alive after menopause. In a year-long human trial, this exact dose added +0.016 g/cm² at the lumbar spine — a meaningful number when the rest of the density curve is going the other way.
Sweeps out the cells that are leaking inflammation onto your new builders.
Worn-out "zombie" cells accumulate in marrow with age and weight loss. They don't die. They sit there leaking signals that nudge nearby stem cells away from becoming bone. Quercetin selectively clears them — the same compound used in the senolytic protocols at the Mayo Clinic and the Buck Institute.
That's it. Three ingredients. Three jobs. Nothing else, because nothing else moves this mechanism.
Bone is slow. The first changes happen inside cells you can't see, on instruments you don't own. But here is what the literature, and our beta users, consistently report:
- Weeks 2–6. NAD+ refills the tank. Cellular energy rises first — most women notice afternoon clarity before they notice anything skeletal.
- Weeks 4–10. Stem cells start choosing builder again. Quercetin clears the senescent cells that were leaking inflammation onto fresh stem cells.
- Months 2–4. Bone-formation markers rise on bloodwork (P1NP, osteocalcin). You won't feel it — but ask your doctor to run them, and they will see it.
- Months 4–8. Density begins to stabilize. The slide stops. Resveratrol's estrogen-mimic action keeps the brakes on bone breakdown at the lumbar spine.
- Month 12+. The number on your DEXA changes. A meaningful T-score move shows up on imaging — the conversation with your doctor becomes a different conversation.
This is a twelve-month protocol. Not a thirty-day experiment. Three bottles is the floor. Six is where the published data sits.
I'll be direct, because at this point in the letter you deserve directness.
An average hip fracture in America costs roughly $50,000 in the first year after the fall — between the surgery, the rehab, the home modifications, and the months you cannot work or drive or pick up a grandchild.
The loss of independence afterward is harder to put a number on. Ask anyone whose mother went into assisted living after a fall. They'll tell you.
So what is a year's worth of insurance against that worth to you?
I have heard answers from "anything" to "five hundred dollars a month." A friend who runs a clinic in Scottsdale told me she'd charge a thousand a bottle and women would still buy it.
We aren't going to do that. Because the women I built this for are not the ones with a thousand a month for a supplement. They are women who worked their whole lives, did the hard thing on the GLP-1, and now deserve to keep what they earned without being squeezed.
One bottle is a 30-day supply. Choose the supply that matches where the science actually moves the needle.
Try Thryve for ninety full days. Take it every morning with breakfast. If at any point in that ninety days you decide it isn't doing what we said it would, send back the bottles — empty, half-empty, full, it doesn't matter — and we'll refund every dollar. No forms. No phone trees. No "why are you returning?" survey. Just an email to care@thirmik.com with the word refund.
Every other "bone health" supplement on the shelf was designed for one thing: post-menopausal calcium support. They are built on the assumption that bone loss is a mineral problem.
That assumption made sense in 1985. It hasn't been the whole truth since the NAD+ research broke in 2013, and it became actively misleading the moment GLP-1 weight loss became mainstream.
Thryve is the first supplement formulated end-to-end for the women this is actually happening to: women in their fifties and sixties, on a GLP-1, watching their pants size go down and not knowing the inside structure was being mortgaged for it.
We are a small formulary in Boulder, Colorado. We make one supplement at a time. We don't run a vitamin catalog. We picked this problem because nobody else was building for it, and because the women in our own lives needed it.
P.S. If you take only one thing from this letter, take this: the fact that you read this far means you are already different from the average GLP-1 user. Most of them will find out about their bones from a scan, or a slip on the ice, or a wrist that won't quite stop hurting. You are finding out now — while there is still time to refill the signal, and let the slow tissue of your skeleton catch up with the fast progress of the rest of your life.
P.P.S. The 90-day guarantee really is unconditional. There is no fine print on the bottom of the bottle. If you try Thryve and decide it isn't for you, we want your money back in your account, not sitting in ours. That is not a marketing line — that is how we want to run a company.
Take care of the skeleton you have. It's the only one you'll get.
— Thirmik Formulary
inside your bones.
You lost it from your stomach. You lost it from your face. You did not know it was moving in somewhere else — somewhere a scale, a mirror, and an annual physical will never find it.
Marrow adiposity — fat growing inside the bone itself — is the unspoken side effect of rapid weight loss on a GLP-1. And it is the actual reason women in their fifties and sixties on Wegovy are landing in the ER with broken hips at five times the normal rate.
If you've spent any time in a doctor's office in the last two years, you've probably heard "Ozempic face." It's the gauntness that creeps into the cheeks when weight comes off fast. You can see it in the mirror. You can fix it with filler.
You haven't heard about Ozempic Bone. Almost nobody has. It doesn't have a name on TV yet — but the scientific name has been around for fifteen years.
It's called marrow adiposity. In plain language: fat growing inside the bone.
Your bones are not solid. They are hollow, and the inside is filled with marrow — the soft, pink, factory-floor tissue that produces your blood cells and your bone-building cells. That marrow is supposed to stay pink.
When it doesn't, when the pink starts turning yellow and waxy, it means stem cells in that bone have stopped becoming bone builders and have started becoming fat cells. Not the kind that store energy. The kind that replace the tissue that used to be there.
You traded the fat on the outside of your body for fat on the inside of your bones. Nobody told you that was the deal — but a 2024 MRI study at the University of North Carolina measured it, in real patients on GLP-1s, against age-matched controls. The marrow-fat fraction increased three to six times faster on the medication than off it.
Three to six times faster.
And here's the thing about marrow fat: it doesn't store energy. It is not metabolically useful. It just sits there, taking up space that bone-building cells used to occupy, and quietly leaking signals that push neighboring stem cells to also become fat instead of bone.
It is structural fat. It is replacing the architecture of your skeleton.
This is not a number we made up to sell you a supplement. It is the published value. MRI studies of healthy women — not women on GLP-1s — show the following progression of marrow adipose tissue in the lumbar spine:
Read that bottom row again.
At sixty, on a GLP-1, the marrow inside your spine is eighty percent fat. There is barely any bone-building tissue left in there. The cells that were supposed to repair the daily wear-and-tear on your vertebrae aren't there anymore. They've been replaced.
This is not "thinning bone." This is bone tissue being substituted for fat tissue, cell by cell, year by year.
Belly fat gets a bad reputation, and some of it is earned. But belly fat is peripheral. It surrounds organs. It is bad for cardiovascular health, but it doesn't replace anything structural.
Marrow fat does. And it does three things no other fat in your body does:
- It takes the place of bone builders. Every stem cell that becomes a marrow adipocyte is a stem cell that didn't become an osteoblast. That single cell decision, repeated millions of times, is the entire mechanism of osteoporosis after weight loss.
- It leaks inflammation onto the cells around it. Marrow adipocytes secrete inflammatory signals (the same ones that drive arthritis) directly into the bone tissue. This actively pushes nearby stem cells away from becoming builders and toward becoming more fat.
- It is biologically self-reinforcing. Once the marrow becomes fat-dominant, the local signaling environment makes it harder for new stem cells to become bone. The fat begets more fat. The slide accelerates.
It's not just that you have less bone-building activity. It's that the fat tissue that took its place is actively making the situation worse, every day, in a feedback loop you cannot feel.
Now you know why bone loss after rapid weight loss is so much steeper than bone loss from age alone. And now you know why calcium can't fix it. You don't have a mineral problem. You have an architecture problem. The factory has been converted into a storage closet.
Inside marrow, every stem cell has two possible futures. It can become a bone builder (an osteoblast) or it can become a fat cell (an adipocyte). The decision is binary, and it is made daily, in millions of cells, throughout your skeleton.
The decision hinges on the level of a single molecule: NAD+.
When NAD+ is loud, stem cells choose builder. When NAD+ goes quiet, stem cells default to fat. That is the entire mechanism, and it is so well-established at this point that the Nobel-tier longevity labs (Sinclair at Harvard, Imai at WashU, the Buck Institute in California) treat it as the lever for skeletal aging.
Here is what happens to your NAD+ levels across a lifespan:
By the time you are sixty and three years into a GLP-1, you have roughly one-third of the signal you had at forty. There is not enough left to keep your marrow choosing builder.
The slide is biological. It is not a matter of willpower. It is not because you didn't try hard enough on calcium or vitamin D or walking. It is because the molecule that makes the decision has fallen below the threshold required to make the right call.
Now we get to the part where the math becomes impossible to argue with.
1.0% on Wegovy vs 0.2% on placebo. Printed in the official label. Never mentioned in a commercial. Hip fracture mortality at age 65+ is roughly 1 in 4 within the first year.
That is on the official label. You can look it up yourself — fda.gov, search "Wegovy label," scroll to section 6.1.
Then in February 2026, the American Academy of Orthopaedic Surgeons published the largest real-world analysis ever done:
- 73,000 patients on GLP-1s, followed across multiple years.
- +29% higher risk of osteoporosis across the full cohort.
- +22% higher risk in the subgroup that matters most — non-diabetic women using GLP-1s purely for weight loss. Women like the ones reading this.
- The risk did not normalize after weight stabilized. The marrow shift kept compounding.
Now I want to give you the part of this letter that is actually good news.
Bone is alive. Marrow is alive. Every single day, your skeleton is breaking down old bone and laying down new bone, on a roughly 90- to 120-day cycle. The fat that's accumulated in your marrow over the last several years is not permanent. The stem cells that have been defaulting to fat can be moved back to defaulting to builder.
The mechanism is known. The literature is settled. When NAD+ rises, marrow stem cells move back toward the builder lineage. When that happens, the marrow-fat fraction starts to fall. When that happens, density stabilizes — and then climbs.
The catch is biological speed. Marrow does not change in a week, and it does not change in a month. Every month you wait is a month the marrow fat is leaking inflammation onto a fresh batch of stem cells. Bone is slow to harm and slow to heal — but both directions happen.
So here is the question. Take a breath before you answer it:
exactly for this mechanism.
The NAD+ Bone Formula.
The first — and currently only — supplement formulated specifically to reverse marrow adiposity in women on GLP-1 medications.
The clinical dose used in the human studies that moved stem cells back to the builder lineage. Reverses the decision your marrow has been making by default.
In a year-long human trial, this exact dose added +0.016 g/cm² at the lumbar spine — when the rest of the curve was supposed to be going down.
A targeted senolytic. Used in the protocols at the Mayo Clinic and the Buck Institute. Clears the cells that are actively making the marrow worse.
No calcium. No vitamin D. Those aren't broken in your body — the signal is. We dose what actually moves the mechanism. Nothing else.
- Weeks 2–6. NAD+ refills the tank. Most women report afternoon clarity and steadier energy first.
- Weeks 4–10. Stem cells start choosing builder again. Quercetin clears the inflammatory cells in marrow.
- Months 2–4. Bone-formation markers (P1NP, osteocalcin) trend upward on bloodwork. Ask your doctor — they will see it.
- Months 4–8. Marrow-fat fraction begins to fall. Density stabilizes. The slide stops.
- Month 12+. A meaningful T-score change shows up on DEXA. The conversation with your doctor becomes a different conversation.
One bottle is a 30-day supply. The science moves the needle at three to six months — so we make those bundles the easiest call.
Take Thryve for ninety days. If at any point you decide it isn't doing what we promised, send the bottles back — empty, half-empty, full, doesn't matter — and we will refund every dollar. No forms, no phone trees, no "why are you returning?" survey. One email to care@thirmik.com with the word refund, and it's done.
Every other "bone health" supplement on the shelf was designed around the idea that bone loss is a mineral problem. They are all variations of calcium plus D3 plus K2.
If marrow adiposity were a mineral problem, those would work. They don't. Because you cannot calcium your way out of an architecture problem. You have to fix the cells that lay the architecture down.
Thryve is the first supplement on the market formulated for that — and specifically for the women this is happening to: fifties, sixties, on a GLP-1, doing everything right on the outside, watching the inside quietly turn.
We are a small formulary in Boulder, Colorado. We make one supplement at a time, for one specific mechanism. We picked this one because the women in our own lives needed it and nobody else was building it.
P.S. If you take only one thing from this letter, take this: fat in your bones is not permanent. It is a tissue choice made daily, by millions of stem cells, on the basis of how loud the signal is. We can make the signal loud again. Most women will not find out about marrow adiposity until their second fracture. You are finding out now.
P.P.S. The 90-day guarantee is unconditional and there is no fine print. If Thryve isn't doing what we promised, we want the money back in your account, not in ours. That's not a marketing line. That's how we want to run a company.
Take care of the skeleton you have. It is the only one you'll get.
— Thirmik Formulary
Six quick questions. We'll calculate a personalized marrow-shift score based on age, menopause status, and GLP-1 use — and tell you what the science recommends from here.
Built around the AAOS 2026 dataset (73,000 patients) and the FDA Wegovy label. Not medical advice, but informed by the same data your endocrinologist is reading.
Cross-referencing your answers against the AAOS 2026 dataset.
—
Based on your score, the science recommends starting the signal-restoration protocol for at least 3 months — bone tissue rebuilds on a 90- to 120-day cycle.
See your recommended supply →This assessment is for educational purposes and is not a medical diagnosis. Please consult your physician before starting any supplement, especially if you are currently using a GLP-1 medication.